Clinical Molecular Imaging Translational Research Unit

Message from the Division Director

Research at the Clinical Molecular Imaging Translational Research Unit focuses on molecular and nuclear imaging with emphasis on improving cancer diagnosis and staging using novel radiotracers and positron emission tomography (PET) imaging, including the use of image fusion techniques.  A specific concentration of our laboratory is amino acid transport imaging for oncologic applications. We carry out collaborative research with a multidisciplinary group of physicians such as urologists, radiation oncologists, hematologic oncologists and surgical oncologists nationally and internationally. We are active in ACOG/ACRIN and are currently involved in the design of international clinical trials. We also carry out a number of projects in other areas such as Y-90 microsphere therapy with the goal of using molecular imaging to improve patient outcomes.

David M Schuster, MD, Director
Clinical Molecular Imaging Translational Research Unit

Faculty

Research Associates

  • Oluwaseun Odewole, MD, MPH
  • Funmilayo Tade, MD, MPH
  • Oyeladun Oyenuga, MD, MPH

Research Nurse

  • Leah Bellamy, RN, MSN, CCRC

Current Research

Highlights and Accomplishments

2014 RRA New Investigator Award
David Schuster, MD

Dr. David Schuster received the Radiology Research Alliance (RRA) 2014 RRA New Investigator Award. This award is a prestigious recognition of promising young investigators by the academic community. The primary mission of the Radiology Research Alliance is to encourage research in radiology and the radiological sciences by helping departments establish and improve their research programs.

Recent Publications

Publications

David M. Schuster, MD

Recent Posters & Oral Presentations

Wooten W, Nye JA, Schuster DM, Nieh PT, Master VA, Votaw JR, Fei BW. Accuracy evaluation of a 3D ultrasound-guided biopsy system. SPIE Medical Imaging - Image-Guided Procedures, Robotic Interventions, and Modeling. Feb. 9-14, 2013, Orlando, FL. Proceedings of SPIE Vol. 8671 (2013)

Okudaira H, Oka S, Nakanishi T, Kobayashi M, Tamagami H, Schuster D, Goodman M, Shirakami Y, Tamai I, Kawai K. Transport mechanism of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (18F-FACBC) PET radiotracer in human prostate cancer. Society of Nuclear Medicine Annual Meeting Abstracts 2013; 54: 393

Savir-Baruch B, Odewole O, Alaei Taleghani P, Master V, Nieh P, Halkar R, Jani A, Goodman M, Yu W, Schuster D. Anti-3-[F18] FACBC uptake pattern in the prostate affects positive predictive value and is associated with the presence of brachytherapy seeds. Society of Nuclear Medicine Annual Meeting Abstracts 2013; 54: 346

Savir-Baruch B, Barron B, Jablonowski E, Plaxton N, Moncayo V, Schuster D. Know my radiotracer: Nuclear medicine prototype flash cards for physicians. Society of Nuclear Medicine Annual Meeting Abstracts 2013; 54: 1254

Alaei Taleghani P, Odewole O, Savir-Baruch B, Nieh P, Master V, Jani A, Goodman M, Wang Z, Yu W, Schuster D. Utility of anti-3-[18F] FACBC PET/CT to predict early biochemical failure following salvage cryotherapy for recurrent prostate cancer. Society of Nuclear Medicine Annual Meeting Abstracts 2013; 54: 345

Savir-Baruch B, Alaei Taleghani P, Odewole O, Amzat R, Halkar R, Bellamy M, Schuster D. Database system to allow accurate analysis of large clinical trials. Society of Nuclear Medicine Annual Meeting Abstracts 2013; 54: 1253

Marchan EM, Goodman MM, Schuster DM, Vakili J, Olson JJ, Hadjipanayis CJ, Brat DJ, Curran WJ, Shu HG, Crocker IR. Impact of FACBC PET in Imaging and GTV Design of Cerebral Gliomas. American Society for Radiation Oncology Annual Meeting Abstracts 2013

Wooten WJ, Nye JA, Schuster DM, Nieh PT, Master VA, Votaw JR, Fei B. Accuracy evaluation of a 3D ultrasound-guided biopsy system. SPIE Medical Imaging, 86712H-86712H-8; 2013

Odewole O, Taleghani P, Jani A, Savir-Baruch B, Bellamy LM, Osunkoya A, Yu W, Halkar R, Nieh P, Master V, Goodman M, Schuster DM. Diagnostic performance of synthetic amino acid anti-3-[18F] FACBC PET in recurrent prostate carcinoma detection. Radiologic Society of North America Annual Meeting 2013, Chicago, IL.

Odewole OA, Jani AB, Taleghani P, Savir-Baruch B, Bellamy LM, Osunkoya AO, Yu W, Halkar RK, Nieh PT, Master VA, Goodman MM, Schuster DM. (2013). Anti-3-[18F] FACBC PET is useful to improve salvage radiotherapy failure rates in recurrent prostate cancer. Radiologic Society of North America Annual Meeting 2013, Chicago, IL.

Contact Information

Nettie Sutton
Department of Radiology
Emory University Hospital
1364 Clifton Road
Atlanta, GA 30322
E-mail: nsutton@emory.edu

Emory University Hospital

Division of Nuclear Medicine & Molecular Imaging
Department of Radiology - Emory University Hospital
1364 Clifton Road, 1st FL #D118
Atlanta, GA 30322